Drugs Made In America Acquisition Corp. (DMAA)

Market Cap	361.11M +4.9%
Revenue (ttm)	n/a
Net Income	6.66M
EPS	0.20
Shares Out	33.72M
PE Ratio	54.21
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	21
Open	n/a
Previous Close	10.71
Day's Range	n/a
52-Week Range	10.22 - 10.72
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About DMAA

Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.

• Industry: Shell Companies
• Sector: Financials
• IPO Date: Jan 28, 2025
• Country: United States
• Stock Exchange: NASDAQ
• Ticker Symbol: DMAA

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Aug 4, 2026

Data Sources Report a data error